Carotid intima-media thickness and cerebral white matter lesions are more advanced in acute ischemic stroke patients with renal dysfunction

Clinical Nephrology

Volumn 76, Issue 4, 2011, Pages 290-295

  Ueda, K ^a   Watanabe, Y ^a   Katsumata, T ^a   Kaneko, T ^a   Otori, T ^a   Utsumi, K ^a   Iino, Y ^a   Katayama, Y ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Acute ischemic stroke; Cerebral white matter; Chronic kidney disease; Intima media thickness

Indexed keywords

AGED; ARTERIAL WALL THICKNESS; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; WHITE MATTER;

AGED; BRAIN ISCHEMIA; CAROTID ARTERY, COMMON; CHI-SQUARE DISTRIBUTION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; RISK FACTORS; STATISTICS, NONPARAMETRIC; STROKE; TOMOGRAPHY, X-RAY COMPUTED; TUNICA INTIMA; TUNICA MEDIA; ULTRASONOGRAPHY;

EID: 82155167360     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN106932     Document Type: Article

References (36)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39 (Suppl 1): S1-S266.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-1305.
3. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004; 351: 1285-1295.
4. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int. 2003; 64: 610-615.
5. Koren-Morag N, Goldbourt U, Tanne D. Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology. 2006; 67: 224-228.
6. Nakayama M, Metoki H, Terawaki H, Ohkubo T, Kikuya M, Sato T, Nakayama K, Asayama K, Inoue R, Hashimoto J, Totsune K, Hoshi H, Ito S, Imai Y. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population--the Ohasama study. Nephrol Dial Transplant. 2007; 22: 1910-1915.
7. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke. 1997; 28: 1932-1939.
8. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM; Rotterdam Scan Study. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003; 34: 1126-1129.
9. Ovbiagele B, Saver JL. Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications. Cerebrovasc Dis. 2006; 22: 83-90.
10. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997; 96: 1432-1437.
11. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Collaborators developing the Japanese equation for estimating GFR, revised equation for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53: 982-992.
12. Fazekas F, Chawluk J, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1-5 T in Alzheimers dementia and normal aging. AJNR Am J Neuroradiol. 1987; 8: 421-426.
13. Brzosko S, Szkolka T, Mysliwiec M. Kidney disease is a negative predictor of 30-day survival after acute ischaemic stroke. Nephron Clin Pract. 2009; 112: c79-c85.
14. Japanese Society of Nephrology. Evidence-based Practice Guideline for the Treatment of CKD 2009; 2009: 17-29
15. Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007; 11: 156-163.
16. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996; 334: 13-18.
17. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA. 1997; 277: 1293-1298.
18. Reynolds K, Gu D, Muntner P, Kusek JW, Chen J, Wu X, Duan X, Chen CS, Klag MJ, Whelton PK, He J. A population-based, prospective study of blood pressure and risk for end-stage renal disease in China. J Am Soc Nephrol. 2007; 18: 1928-1935.
19. Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension. 2003; 41: 1341-1345.
20. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348: 383-393.
21. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358: 580-591.
22. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med. 1997; 157: 1413-1418.
23. Irie F, Iso H, Sairenchi T, Fukasawa N, Yamagishi K, Ikehara S, Kanashiki M, Saito Y, Ota H, Nose T. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 2006; 69: 1264-1271.
24. Katsumata T, Nishiyama Y, Yamaguchi H, Otori T, Nakamura H, Tanaka N, Katayama Y. Extracranial carotid plaque is increasing in Japanese ischemic stroke patients. Acta Neurol Scand. 2007; 116: 20-25.
25. Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M. Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke. 2000; 31: 2616-2622.
26. Kimura K, Kazui S, Minematsu K, Yamaguchi T; Japan Multicenter Stroke Investigator's Collaboration. Analysis of 16,922 patients with acute ischemic stroke and transient ischemic attack in Japan. A hospital-based prospective registration study. Cerebrovasc Dis. 2004; 18: 47-56.
27. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996; 27: 1274-1282.
28. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, Hofman A, Jolles J, van Gijn J, Breteler MM. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001; 70: 9-14.
29. Dufouil C, de Kersaint-Gilly A, Besançon V, Levy C, Auffray E, Brunnereau L, Alpérovitch A, Tzourio C. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology. 2001; 56: 921-926.
30. Fazekas F, Niederkorn K, Schmidt R, Offenbacher H, Horner S, Bertha G, Lechner H. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke. 1988; 19: 1285-1288.
31. Wright CB, Paik MC, Brown TR, Stabler SP, Allen RH, Sacco RL, DeCarli C. Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke. 2005; 36: 1207-1211.
32. Khatri M, Wright CB, Nickolas TL, Yoshita M, Paik MC, Kranwinkel G, Sacco RL, DeCarli C. Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke. 2007; 38: 3121-3126.
33. Touboul PJ, Elbaz A, Koller C, Lucas C, Adraï V, Chédru F, Amarenco P; The GENIC Investigators. Common carotid artery intima-media thickness and brain infarction: the Étude du Profil Génétique de l'Infarctus Cérébral (GENIC) Case-control study. Circulation. 2000; 102: 313-318.
34. Hollander M, Bots ML, Del Sol AI, Koudstaal PJ, Witteman JC, Grobbee DE, Hofman A, Breteler MM. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation. 2002; 105: 2872-2877.
35. Lernfelt B, Forsberg M, Blomstrand C, Mellström D, Volkmann R. Cerebral atherosclerosis as predictor of stroke and mortality in representative elderly population. Stroke. 2002; 33: 224-229.
36. Shoji T, Emoto M, Tabata T, Kimoto E, Shinohara K, Maekawa K, Kawagishi T, Tahara H, Ishimura E, Nishizawa Y. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int. 2002; 61: 2187-2192.